Stocks News

LAST PRICE
101.8700
TODAY'S CHANGE (%)
Trending Down-0.0100 (-0.0098%)

Bid / Lots
101.5000/ 1
Ask / Lots
101.8400/ 2
Open / Previous Close
102.0000 / 101.8800
Day Range
Low 100.9450
High 102.5300
52 Week Range
Low 98.6000
High 134.6300
Volume
9,182,554
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 1, 2024
- DJ Merck Is Maintained at Equal-Weight by Wells Fargo, from 2:55PM ET on Friday Nov 01, 2024 by Dow Jones
  2:55PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: MRK
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/MRK/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 01, 2024 14:55 ET (18:55 GMT)
- Sector Update: Health Care Stocks Higher Friday Afternoon, from 2:01PM ET on Friday Nov 01, 2024 by MT Newswires
  2:01PM ET on Friday Nov 01, 2024 by MT Newswires
  Companies Mentioned: MRK, TOVX, WAT, CAH
  02:01 PM EDT, 11/01/2024 (MT Newswires) -- Health care stocks were advancing Friday afternoon, with the NYSE Health Care Index rising 0.7% and the Health Care Select Sector SPDR Fund (XLV) up 0.6%. The iShares Biotechnology ETF (IBB) climbed 1.3%. I...
- DJ Merck Is Maintained at Outperform by BMO Capital, from 12:17PM ET on Friday Nov 01, 2024 by Dow Jones
  12:17PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: MRK
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/MRK/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 01, 2024 12:17 ET (16:17 GMT)
- UBS Adjusts Price Target on Merck to $125 From $136, Maintains Buy Rating, from 10:15AM ET on Friday Nov 01, 2024 by MT Newswires
  10:15AM ET on Friday Nov 01, 2024 by MT Newswires
  Companies Mentioned: MRK
  10:15 AM EDT, 11/01/2024 (MT Newswires) -- Merck (MRK) has an average outperform rating and price target range of $110 to $155, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from major banks...
- DJ Merck Is Maintained at Equal-Weight by Morgan Stanley, from 9:28AM ET on Friday Nov 01, 2024 by Dow Jones
  9:28AM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: MRK
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/MRK/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 01, 2024 09:28 ET (13:28 GMT)

Today
- Sector Update: Health Care Stocks Softer in Afternoon Trading, from 6 hours ago by MT Newswires
  6 hours ago by MT Newswires
  Companies Mentioned: BNTX, AZN, PACS
- BioNTech Sees Full-Year Revenue at Low End of Guidance; Third-Quarter Results Rise, from 7 hours ago by MT Newswires
  7 hours ago by MT Newswires
  Companies Mentioned: PFE, BNTX
- DJ Novartis AG Rises Monday, Outperforms Market, from 7 hours ago by Dow Jones
  7 hours ago by Dow Jones
  Companies Mentioned: NVS
- DJ AstraZeneca PLC Stock Rises Monday, Outperforms Market, from 8 hours ago by Dow Jones
  8 hours ago by Dow Jones
  Companies Mentioned: AZN
- DJ AbbVie Raised to Buy From Hold by Argus Research, from 8 hours ago by Dow Jones
  8 hours ago by Dow Jones
  Companies Mentioned: ABBV
- DJ AstraZeneca Says Obesity Pill Shows Minimal Side Effects in Early Trial, from 8 hours ago by Dow Jones
  8 hours ago by Dow Jones
  Companies Mentioned: AZN
- Market Chatter: AstraZeneca Says Obesity Pill Well-Tolerated by Patients, from 9 hours ago by MT Newswires
  9 hours ago by MT Newswires
  Companies Mentioned: AZN
- --AstraZeneca Obesity Pill Well-Tolerated in Type-2 Diabetes Patients, Bloomberg Reports, from 9 hours ago by MT Newswires
  9 hours ago by MT Newswires
  Companies Mentioned: AZN
- Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference, from 10 hours ago by Dow Jones
  10 hours ago by Dow Jones
  Companies Mentioned: PFE
- Argus Upgrades AbbVie to Buy From Hold, Price Target is $220, from 12 hours ago by MT Newswires
  12 hours ago by MT Newswires
  Companies Mentioned: ABBV

Merck & Co Inc
NYSE:MRKUnited States

Search Criteria

Nov 1, 2024

DJ Merck Is Maintained at Equal-Weight by Wells Fargo, from 2:55PM ET on Friday Nov 01, 2024 by Dow Jones

Sector Update: Health Care Stocks Higher Friday Afternoon, from 2:01PM ET on Friday Nov 01, 2024 by MT Newswires

DJ Merck Is Maintained at Outperform by BMO Capital, from 12:17PM ET on Friday Nov 01, 2024 by Dow Jones

UBS Adjusts Price Target on Merck to $125 From $136, Maintains Buy Rating, from 10:15AM ET on Friday Nov 01, 2024 by MT Newswires

DJ Merck Is Maintained at Equal-Weight by Morgan Stanley, from 9:28AM ET on Friday Nov 01, 2024 by Dow Jones

Peers Headlines

Today

Sector Update: Health Care Stocks Softer in Afternoon Trading, from 6 hours ago by MT Newswires

BioNTech Sees Full-Year Revenue at Low End of Guidance; Third-Quarter Results Rise, from 7 hours ago by MT Newswires

DJ Novartis AG Rises Monday, Outperforms Market, from 7 hours ago by Dow Jones

DJ AstraZeneca PLC Stock Rises Monday, Outperforms Market, from 8 hours ago by Dow Jones

DJ AbbVie Raised to Buy From Hold by Argus Research, from 8 hours ago by Dow Jones

DJ AstraZeneca Says Obesity Pill Shows Minimal Side Effects in Early Trial, from 8 hours ago by Dow Jones

Market Chatter: AstraZeneca Says Obesity Pill Well-Tolerated by Patients, from 9 hours ago by MT Newswires

--AstraZeneca Obesity Pill Well-Tolerated in Type-2 Diabetes Patients, Bloomberg Reports, from 9 hours ago by MT Newswires

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference, from 10 hours ago by Dow Jones

Argus Upgrades AbbVie to Buy From Hold, Price Target is $220, from 12 hours ago by MT Newswires